Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Net Sales
1,200.09
1,016.94
853.17
712.93
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
1,200.09
1,016.94
853.17
712.93
Raw Material Cost
264.31
184.54
167.07
157.26
Purchase of Finished goods
55.99
56.74
28.77
30.73
(Increase) / Decrease In Stocks
-14.79
-12.08
-15.63
-23.98
Employee Cost
138.93
123.05
110.28
95.69
Power Cost
112.23
104.97
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Other Expenses
137.09
128.16
219.39
179.96
Total Expenditure (Excl Depreciation)
693.76
585.38
509.88
439.66
Operating Profit (PBDIT) excl Other Income
506.33
431.56
343.29
273.27
Other Income
44.45
33.78
35.31
23.42
Operating Profit (PBDIT)
550.78
465.34
378.60
296.69
Interest
0.53
2.55
4.51
5.48
Exceptional Items
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
550.25
462.79
374.09
291.21
Depreciation
54.37
53.59
54.03
50.05
Profit Before Tax
495.87
409.20
320.05
241.16
Tax
122.91
104.46
81.93
62.59
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
372.96
304.73
238.13
178.57
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
372.96
304.73
238.13
178.57
Share in Profit of Associates
-1.32
3.37
1.96
-3.64
Minority Interest
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
371.64
308.10
240.09
174.93
Equity Capital
10.46
10.46
10.46
9.51
Face Value
1.0
1.0
1.0
10.0
Reserves
1,802.26
1,516.18
1,279.54
1,093.71
Earnings per share (EPS)
35.53
29.46
22.95
16.72
Diluted Earnings per share
35.52
29.45
22.95
183.34
Operating Profit Margin (Excl OI)
42.19%
42.44%
40.24%
38.33%
Gross Profit Margin
45.85%
45.51%
43.85%
40.85%
PAT Margin
30.97%
30.3%
28.14%
24.54%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 18.01% vs 19.20% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 20.62% vs 28.33% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 17.33% vs 25.71% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -79.22% vs -43.46% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Concord Biotech With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
1,200.09
4,429.50
-3,229.41
-72.91%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,200.09
4,429.50
-3,229.41
-72.91%
Raw Material Cost
264.31
536.20
-271.89
-50.71%
Purchase of Finished goods
55.99
166.10
-110.11
-66.29%
(Increase) / Decrease In Stocks
-14.79
-12.50
-2.29
-18.32%
Employee Cost
138.93
594.50
-455.57
-76.63%
Power Cost
112.23
0.00
112.23
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
137.09
949.20
-812.11
-85.56%
Total Expenditure (Excl Depreciation)
693.76
2,233.50
-1,539.74
-68.94%
Operating Profit (PBDIT) excl Other Income
506.33
2,196.00
-1,689.67
-76.94%
Other Income
44.45
354.50
-310.05
-87.46%
Operating Profit (PBDIT)
550.78
2,550.50
-1,999.72
-78.41%
Interest
0.53
23.90
-23.37
-97.78%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
550.25
2,526.60
-1,976.35
-78.22%
Depreciation
54.37
235.20
-180.83
-76.88%
Profit Before Tax
495.87
2,291.40
-1,795.53
-78.36%
Tax
122.91
408.00
-285.09
-69.88%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
372.96
1,883.40
-1,510.44
-80.20%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
372.96
1,883.40
-1,510.44
-80.20%
Share in Profit of Associates
-1.32
0.00
-1.32
Minority Interest
0.00
2.00
-2.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
371.64
1,885.40
-1,513.76
-80.29%
Equity Capital
10.46
35.80
-25.34
-70.78%
Face Value
1.00
2.00
0.00
Reserves
1,802.26
7,571.20
-5,768.94
-76.20%
Earnings per share (EPS)
35.53
105.33
-69.80
-66.27%
Diluted Earnings per share
35.52
105.26
-69.74
-66.25%
Operating Profit Margin (Excl OI)
42.19%
49.58%
0.00
-7.39%
Gross Profit Margin
45.85%
57.04%
0.00
-11.19%
PAT Margin
30.97%
42.52%
0.00
-11.55%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,200.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.01% vs 19.20% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 371.64 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.62% vs 28.33% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 506.33 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.33% vs 25.71% in Mar 2024
Annual - Interest
Interest 0.53 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -79.22% vs -43.46% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 42.19%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
